1. Home
  2. RVMD vs VNO Comparison

RVMD vs VNO Comparison

Compare RVMD & VNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • VNO
  • Stock Information
  • Founded
  • RVMD 2014
  • VNO 1946
  • Country
  • RVMD United States
  • VNO United States
  • Employees
  • RVMD N/A
  • VNO N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • VNO Real Estate Investment Trusts
  • Sector
  • RVMD Health Care
  • VNO Real Estate
  • Exchange
  • RVMD Nasdaq
  • VNO Nasdaq
  • Market Cap
  • RVMD 7.5B
  • VNO 7.3B
  • IPO Year
  • RVMD 2020
  • VNO N/A
  • Fundamental
  • Price
  • RVMD $43.81
  • VNO $41.23
  • Analyst Decision
  • RVMD Strong Buy
  • VNO Hold
  • Analyst Count
  • RVMD 16
  • VNO 11
  • Target Price
  • RVMD $73.56
  • VNO $38.64
  • AVG Volume (30 Days)
  • RVMD 2.1M
  • VNO 2.1M
  • Earning Date
  • RVMD 11-05-2025
  • VNO 11-03-2025
  • Dividend Yield
  • RVMD N/A
  • VNO 1.80%
  • EPS Growth
  • RVMD N/A
  • VNO 4453.28
  • EPS
  • RVMD N/A
  • VNO 4.07
  • Revenue
  • RVMD N/A
  • VNO $1,889,783,000.00
  • Revenue This Year
  • RVMD N/A
  • VNO N/A
  • Revenue Next Year
  • RVMD $454.11
  • VNO $2.94
  • P/E Ratio
  • RVMD N/A
  • VNO $10.11
  • Revenue Growth
  • RVMD N/A
  • VNO 0.58
  • 52 Week Low
  • RVMD $29.17
  • VNO $29.68
  • 52 Week High
  • RVMD $62.40
  • VNO $46.63
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 63.22
  • VNO 58.04
  • Support Level
  • RVMD $39.73
  • VNO $41.63
  • Resistance Level
  • RVMD $47.21
  • VNO $43.37
  • Average True Range (ATR)
  • RVMD 1.81
  • VNO 1.09
  • MACD
  • RVMD 0.57
  • VNO 0.29
  • Stochastic Oscillator
  • RVMD 64.77
  • VNO 66.19

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About VNO Vornado Realty Trust

Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.

Share on Social Networks: